Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/111214| Title: | Open-label, phase 2 study of pembrolizumab in children and young adults with newly diagnosed Classical Hodgkin Lymphoma (CHL) with slow early response to front-line chemotherapy |
| Author(s): | Vinti, Luciana Daw, Stephen Sabado Alvarez, Constantino Fagioli, Franca Beishuizen, Auke Michel, Gerard Moleti, Maria Luisa Cepelova, Michaela Thorwarth, Anne  Rigaud, Charlotte Lopez De Sabando, Diego Plaza Landman-Parker, Judith Shen, Juan Pillai, Pallavi Marinello, Patricia Mauz-Körholz, Christine |
| Issue Date: | 2023 |
| Type: | Article |
| Language: | English |
| URI: | https://opendata.uni-halle.de//handle/1981185920/113168 http://dx.doi.org/10.25673/111214 |
| Open Access: |  Open access publication |
| License: |  (CC BY-NC-ND 4.0) Creative Commons Attribution NonCommercial NoDerivatives 4.0 |
| Journal Title: | HemaSphere |
| Publisher: | Wolters Kluwer Health |
| Publisher Place: | [Philadelphia, Pennsylvania] |
| Volume: | 7 |
| Issue: | S3 |
| Original Publication: | 10.1097/01.hs9.0000967772.35060.76 |
| Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| s215__keynote_667__open_label,_phase_2_study_of.117.pdf | 932.05 kB | Adobe PDF |  View/Open |